From: Gait initiation and termination strategies in patients with Prader-Willi syndrome
GAIT TERMINATION | |||
---|---|---|---|
PWS | OG | HG | |
DURATION [s] | |||
TSPA1 | 0.40 (0.08) | 0.46 (0.13) | 0.43 (0.11) |
TSPA2A | 0.19 (0.16)* | 0.19 (0.15)* | 0.14 (0.09) |
TSPA2B | 0.17 (0.10) | 0.13 (0.11) | 0.15 (0.13) |
TSPA3 | 0.55 (0.12)*+ | 0.50 (0.22)* | 0.39 (0.05) |
TTOT | 1.37 (0.25)* | 1.29 (0.40)* | 1.12 (0.23) |
VELOCITY [m/s] | |||
VSPA 1(x) | 0.26 (0.15)* | 0.29 (0.12)* | 0.37 (0.12) |
VSPA2A(x) | 0.06 (0.07) | 0.07 (0.07) | 0.07 (0.09) |
VSPA2B(x) | 0.08 (0.07) | 0.06 (0.09) | 0.10 (0.07) |
VSPA3(x) | 0.03 (0.04) | 0.03 (0.04) | 0.03 (0.03) |
VSPA1 (z) | 0.05 (0.09) | 0.06 (0.09) | 0.05 (0.09) |
VSPA2A(z) | 0.19 (0.15)*+ | 0.27 (0.23) | 0.25 (0.25) |
VSPA2B(z) | 0.33 (0.21) | 0.33 (0.38) | 0.27 (0.21) |
VSPA3(z) | 0.02 (0.03)*+ | 0.04 (0.05) | 0.04 (0.06) |
LENGHT [mm/m] | |||
LSPA1 | 0.083 (0.038) | 0.088 (0.033) | 0.095 (0.033) |
LSPA2A | 0.031 (0.018)* | 0.029 (0.031)* | 0.025 (0.023) |
LSPA2B | 0.034 (0.013) | 0.032 (0.029) | 0.030 (0.017) |
LSPA3 | 0.025 (0.019) | 0.028 (0.019)* | 0.022 (0.014) |
LTOT | 0.175 (0.068) | 0.180 (0.053) | 0.175 (0.034) |